Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DiStok: Optimisation of High Flow Oxygen Therapy Settings by Depth Camera
NCT06819644Phase 3Recruiting
- Sponsor
- Centre Hospitalier Universitaire de Brest
- Start
- Apr 2026
- Primary completion
- Oct 2030
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial in hypoxemic respiratory failure (2 arms), sponsored by Centre Hospitalier Universitaire de Brest. Primary endpoint: Use of intubation within 28 days of randomization. Started Apr 2026; status: recruiting.
02
Conditions
hypoxemic respiratory failure
Beyond the preview
Go deeper on NCT06819644.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06819644.